{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:28:26Z","timestamp":1789097306887,"version":"build-2803163510"},"reference-count":77,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anti-infective Therapy"],"published-print":{"date-parts":[[2021,8,3]]},"DOI":"10.1080\/14787210.2021.1866545","type":"journal-article","created":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T10:19:15Z","timestamp":1609237155000},"page":"1029-1037","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":43,"title":["A review on favipiravir: the properties, function, and usefulness to treat COVID-19"],"prefix":"10.1080","volume":"19","author":[{"given":"Seyed MohammadReza","family":"Hashemian","sequence":"first","affiliation":[{"name":"Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran"},{"name":"Chronic Respiratory Diseases Research Center (CRDRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayebeh","family":"Farhadi","sequence":"additional","affiliation":[{"name":"Chronic Respiratory Diseases Research Center (CRDRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Akbar","family":"Velayati","sequence":"additional","affiliation":[{"name":"Chronic Respiratory Diseases Research Center (CRDRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,12,29]]},"reference":[{"key":"cit0001","unstructured":"WHO Coronavirus Disease (COVID-19) Dashboard. World Health Organization. [cited 2020 Nov 24]. Available from: https:\/\/covid19.who.int\/"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00221-18"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1038\/d41573-020-00016-0"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.17.20037432"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1811345115"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.562615"},{"key":"cit0007","author":"Rambaut A","year":"2020","journal-title":"bioRxiv"},{"key":"cit0008","author":"Boni MF","year":"2020","journal-title":"bioRxiv"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.058"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01739-09"},{"key":"cit0011","unstructured":"Fuji Film Toyama Pharmaceuticals. [Media release. Approval of antiinfluenza drug \u201cAvigan 200 mg tablet\u201d in Japan]. Available from: https:\/\/www.toyama-chemical.co.jp\/news\/detail\/140324.html (Accessed on 2016 Jun 12) Japanese."},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2018.03.003"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1016\/S2055-6640(20)30016-9"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1016\/j.eng.2020.03.007"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1252"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1017\/dmp.2014.151"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa105"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.2183\/pjab.93.027"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.4149\/av_2017_01_48"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.3.981-986.2005"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-001-0308-0"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.70.4.1174"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.15.098731"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.03679"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002535"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01653-19"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00380-18"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02346-12"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01400-17"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164691"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00649-13"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068347"},{"key":"cit0033","author":"Goldhill D","year":"2020","journal-title":"bioRxiv"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2013.11.006"},{"key":"cit0035","doi-asserted-by":"crossref","unstructured":"Yin W, Mao C, Luan X, et al. Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir. Science. 2020. DOI:10.1126\/science.abc1560","DOI":"10.1101\/2020.04.08.032763"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2836(02)01033-1"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkp904"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2005.02.017"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1007626107"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.3390\/v11080745"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2008.07.009"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01074-08"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.3851\/IMP3180"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-017-3436-8"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.3390\/v10020072"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2017.07.010"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004695"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv522"},{"issue":"5","key":"cit0049","first-page":"855","volume":"65","author":"Raabe VN","year":"2017","journal-title":"ClinInfect Dis"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1038\/srep14775"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00356-07"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001342"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2015.12.006"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002614"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00061-15"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01942-16"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2014.01.016"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2017.08.004"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002804"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1729"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00886-13"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw571"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2014.02.014"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001967"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2014.01.012"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2017.12.021"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2017.12.020"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2017.04.018"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv586"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00709-16"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.3390\/ph13050096"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(20)30114-5"},{"key":"cit0073","unstructured":"[cited 2020 Aug 13]. Available from:https:\/\/www.trialsitenews.com\/russia-ministry-of-health-approves-avifavir-favipiravir-for-covid-19-patients-cuts-duration-of-illness-by-over-50\/"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S261154"},{"key":"cit0075","doi-asserted-by":"crossref","unstructured":"Ivashchenko AA, Dmitriev KA, Vostokova NV, et al. AVIFAVIR for treatment of patients with moderate COVID-19: interim results of a phase II\/III multicenter randomized clinical trial. medRxiv. 2020.","DOI":"10.1093\/cid\/ciaa1176"},{"key":"cit0076","unstructured":"[cited 2020 Aug 13]. Available from: https:\/\/www.contagionlive.com\/news\/fda-clears-favipiravir-covid19-facility-outbreak-prevention-study"},{"key":"cit0077","doi-asserted-by":"crossref","unstructured":"Du YX, Chen XP Favipiravir: pharmacokinetics and concerns about clinical trials for 2019\u2010nCoV infection. Clinical Pharmacology & Therapeutics. 2020. DOI:10.1002\/cpt.1844","DOI":"10.1002\/cpt.1844"}],"container-title":["Expert Review of Anti-infective Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14787210.2021.1866545","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T11:43:06Z","timestamp":1641296586000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14787210.2021.1866545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,29]]},"references-count":77,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8,3]]}},"alternative-id":["10.1080\/14787210.2021.1866545"],"URL":"https:\/\/doi.org\/10.1080\/14787210.2021.1866545","relation":{},"ISSN":["1478-7210","1744-8336"],"issn-type":[{"value":"1478-7210","type":"print"},{"value":"1744-8336","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,29]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-08-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}